Gene · 7068
Papers3,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effect of diet-induced weight-loss on subcutaneous adipose tissue expression of genes associated with thyroid hormone action. | Clin Nutr | 2024 | 39527910 | PubTator, text mining | PubMed |
| Management strategies for metabolic dysfunction-associated steatotic liver disease (MASLD). | Am J Manag Care | 2024 | 39513734 | PubTator, text mining | PubMed |
| Effectiveness of Resmetirom in Reducing Cholesterol Levels in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. | Cureus | 2024 | 39493200 | PubTator, text mining | PubMed |
| Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes. | Mol Metab | 2024 | 39481850 | PubTator, text mining | PubMed |
| Drug treatment for metabolic dysfunction-associated steatotic liver disease: Progress and direction. | Chin Med J (Engl) | 2024 | 39470028 | PubTator, text mining | PubMed |
| Comparative efficacy of THR-β agonists, FGF-21 analogues, GLP-1R agonists, GLP-1-based polyagonists, and Pan-PPAR agonists for MASLD: A systematic review and network meta-analysis. | Metabolism | 2024 | 39357599 | PubTator, text mining | PubMed |
| An insight into the updated pharmacotherapy of metabolic-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatohepatitis (MASH) in lean individuals: a review. | Hosp Pract (1995) | 2024 | 39356238 | PubTator, text mining | PubMed |
| Increased cardiovascular morbidity and reduced life expectancy in a large Italian cohort of patients with resistance to thyroid hormone β (RTHβ). | Eur J Endocrinol | 2024 | 39327977 | PubTator, text mining | PubMed |
| Epigenetic regulation of thyroid hormone action in human metabolic dysfunction-associated steatohepatitis. | Eur Thyroid J | 2024 | 39312733 | PubTator, text mining | PubMed |
| Rezdiffra™ (resmetirom): a THR-β agonist for non-alcoholic steatohepatitis. | Trends Pharmacol Sci | 2024 | 39304473 | PubTator, text mining | PubMed |
| ToxDAR: A Workflow Software for Analyzing Toxicologically Relevant Proteomic and Transcriptomic Data, from Data Preparation to Toxicological Mechanism Elucidation. | Int J Mol Sci | 2024 | 39273492 | PubTator, text mining | PubMed |
| Automated design of multi-target ligands by generative deep learning. | Nat Commun | 2024 | 39261471 | PubTator, text mining | PubMed |
| Diabetes as a risk factor for MASH progression. | Diabetes Res Clin Pract | 2024 | 39245423 | PubTator, text mining | PubMed |
| Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH. | J Med Chem | 2024 | 39221768 | PubTator, text mining | PubMed |
| Thyroid Hormone Resistance: A 17-Year Follow-up Case Report. | Endocr Metab Immune Disord Drug Targets | 2024 | 39192655 | PubTator, text mining | PubMed |
| Circular PCR as an efficient and precise umbrella of methods for the generation of circular dsDNA with staggered nicks: Mechanism and types. | Biol Methods Protoc | 2024 | 39139995 | PubTator, text mining | PubMed |
| Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals. | Curr Obes Rep | 2024 | 39110384 | PubTator, text mining | PubMed |
| Resistance to Thyroid Hormone Beta Due to THRB Mutation in a Patient Misdiagnosed With TSH-Secreting Pituitary Adenoma. | JCEM Case Rep | 2024 | 39091608 | PubTator, text mining | PubMed |
| Correction: Regulation of cancer stem cell activity by thyroid hormone receptor β. | Oncogene | 2024 | 39020073 | PubTator, text mining | PubMed |
| Exploring Selenoprotein P in Liver Cancer: Advanced Statistical Analysis and Machine Learning Approaches. | Cancers (Basel) | 2024 | 39001444 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7068/papers?page=14